BIOS
BioPlus Acquisition Corp. Class A Ordinary Shares
BIOS
BIOS
Delisted
BIOS was delisted on the 6th of October, 2023.
67 hedge funds and large institutions have $200M invested in BioPlus Acquisition Corp. Class A Ordinary Shares in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
Holders
67
Holding in Top 10
–
Calls
$101K
Puts
–
Top Buyers
| 1 | +$6.62M | |
| 2 | +$2.51M | |
| 3 | +$2.51M | |
| 4 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
+$2.33M |
| 5 |
Parallax Volatility Advisers
San Francisco,
California
|
+$2.23M |
Top Sellers
| 1 | -$7.09M | |
| 2 | -$4.03M | |
| 3 | -$2.51M | |
| 4 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$2.06M |
| 5 |
BCM
Basso Capital Management
Stamford,
Connecticut
|
-$1.44M |